kth.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Empagliflozin improves insulin sensitivity in patients with a recent coronary syndrome and newly detected dysglycaemia
Karolinska Inst, Med, Stockholm, Sweden.;Södertälje Hosp, Stockholm, Sweden..
Karolinska Inst, Med, Stockholm, Sweden..
Karolinska Inst, Med, Stockholm, Sweden.;Karolinska Univ Hosp, Stockholm, Sweden..
Karolinska Inst, Med, Stockholm, Sweden.;Capio St Gorans Hosp, Stockholm, Sweden..
Show others and affiliations
2023 (English)In: Diabetologia, ISSN 0012-186X, E-ISSN 1432-0428, Vol. 66, no SUPPL 1, p. S243-S244Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Springer Nature , 2023. Vol. 66, no SUPPL 1, p. S243-S244
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:kth:diva-339821ISI: 001065473000477OAI: oai:DiVA.org:kth-339821DiVA, id: diva2:1813681
Note

QC 20231121

Available from: 2023-11-21 Created: 2023-11-21 Last updated: 2023-11-21Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records

Näsman, Per

Search in DiVA

By author/editor
Näsman, Per
By organisation
Real Estate Economics and Finance
In the same journal
Diabetologia
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 31 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf